Panagora Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,135
| Closed | -$7K | – | 2426 |
|
|
2021
Q2 | $7K | Sell |
2,135
-56,785
| -96% | -$179K | ﹤0.01% | 2388 |
|
|
2021
Q1 | $203K | Sell |
58,920
-133,653
| -69% | -$416K | ﹤0.01% | 1702 |
|
|
2020
Q4 | $485K | Sell |
192,573
-520
| -0.3% | -$1.13K | ﹤0.01% | 1240 |
|
|
2020
Q3 | $407K | Hold |
193,093
| – | – | ﹤0.01% | 1253 |
|
|
2020
Q2 | $432K | Buy |
193,093
+9,017
| +5% | +$23.2K | ﹤0.01% | 1249 |
|
|
2020
Q1 | $465K | Sell |
184,076
-42,036
| -19% | -$103K | ﹤0.01% | 1151 |
|
|
2019
Q4 | $595K | Buy |
226,112
+39,009
| +21% | +$117K | ﹤0.01% | 1249 |
|
|
2019
Q3 | $674K | Buy |
187,103
+185,791
| +14,161% | +$658K | ﹤0.01% | 1179 |
|
|
2019
Q2 | $4K | Sell |
1,312
-5,381
| -80% | -$19K | ﹤0.01% | 2496 |
|
|
2019
Q1 | $18K | Sell |
6,693
-10,870
| -62% | -$35.6K | ﹤0.01% | 2285 |
|
|
2018
Q4 | $49K | Hold |
17,563
| – | – | ﹤0.01% | 1971 |
|
|
2018
Q3 | $72K | Hold |
17,563
| – | – | ﹤0.01% | 1942 |
|
|
2018
Q2 | $91K | Sell |
17,563
-59,140
| -77% | -$360K | ﹤0.01% | 1876 |
|
|
2018
Q1 | $420K | Sell |
76,703
-400,723
| -84% | -$2.82M | ﹤0.01% | 1439 |
|
|
2017
Q4 | $3.89M | Sell |
477,426
-55,718
| -10% | -$532K | 0.01% | 626 |
|
|
2017
Q3 | $5.58M | Buy |
533,144
+58,907
| +12% | +$654K | 0.02% | 541 |
|
|
2017
Q2 | $5.24M | Buy |
474,237
+209,256
| +79% | +$1.95M | 0.02% | 564 |
|
|
2017
Q1 | $2.22M | Buy |
264,981
+32,679
| +14% | +$230K | 0.01% | 842 |
|
|
2016
Q4 | $1.61M | Buy |
232,302
+219,670
| +1,739% | +$1.4M | 0.01% | 991 |
|
|
2016
Q3 | $64K | Sell |
12,632
-4,896
| -28% | -$29.2K | ﹤0.01% | 2067 |
|
|
2016
Q2 | $105K | Sell |
17,528
-14,383
| -45% | -$79.8K | ﹤0.01% | 1898 |
|
|
2016
Q1 | $145K | Buy |
31,911
+14,383
| +82% | +$64K | ﹤0.01% | 1762 |
|
|
2015
Q4 | $79K | Hold |
17,528
| – | – | ﹤0.01% | 1865 |
|
|
2015
Q3 | $56K | Hold |
17,528
| – | – | ﹤0.01% | 1967 |
|
|
2015
Q2 | $53K | Sell |
17,528
-35,377
| -67% | -$99.4K | ﹤0.01% | 2127 |
|
|
2015
Q1 | $156K | Sell |
52,905
-5,427
| -9% | -$17.8K | ﹤0.01% | 1778 |
|
|
2014
Q4 | $259K | Sell |
58,332
-14,432
| -20% | -$68.8K | ﹤0.01% | 1533 |
|
|
2014
Q3 | $375K | Sell |
72,764
-34,871
| -32% | -$186K | ﹤0.01% | 1408 |
|
|
2014
Q2 | $565K | Sell |
107,635
-6,511
| -6% | -$28.2K | ﹤0.01% | 1336 |
|
|
2014
Q1 | $475K | Buy |
+114,146
| New | +$391K | ﹤0.01% | 1435 |
|
|
2013
Q3 | – | Sell |
-35,278
| Closed | -$73K | – | 2373 |
|
|
2013
Q2 | $73K | Buy |
+35,278
| New | +$77.9K | ﹤0.01% | 1925 |
|
Other funds holding ENZ
HFA
RAM
EGA
VCA
Panagora Asset Management's ENZ Position: Q3 2021 in Review
Panagora Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2021, closing a stake of 2,135 shares — an estimated $7K sold.
Panagora Asset Management first reported a position in ENZ in Q2 2013 and held it in 31 quarters. The position peaked at $5.58M in Q3 2017. 65 funds tracked by Wall St. Rank hold ENZ as of Q3 2021.
- Panagora Asset Management reported no remaining Enzo Biochem, Inc. position as of Q3 2021 after selling out during the quarter.
- Panagora Asset Management sold 2,135 Enzo Biochem, Inc. shares in Q3 2021, an estimated $7K.
- Panagora Asset Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 31 quarters.
- Panagora Asset Management's Enzo Biochem, Inc. position peaked at $5.58M in Q3 2017.
- 65 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2021.
Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.